Metaiodobenzylguanidine Myocardial Scintigraphy Identifies Premotor Parkinson's Disease During a Negative Dopamine Transporter Scan

J Am Geriatr Soc. 2015 Nov;63(11):2428-30. doi: 10.1111/jgs.13801.

Authors

Affiliations

¹ Division of Neurology, Department of Internal Medicine, Sakura Medical Center, Toho University, Sakura, Japan.
² Pharmaceutical Unit, Sakura Medical Center, Toho University, Sakura, Japan.
³ Department of Radiology, Sakura Medical Center, Toho University, Sakura, Japan.
⁴ Department of Gastroenterology, Sakura Medical Center, Toho University, Sakura, Japan.

PMID: 26603075
DOI: 10.1111/jgs.13801

No abstract available

Publication types

Clinical Study
Letter

MeSH terms

3-Iodobenzylguanidine*
Aged
Aged, 80 and over
Dopamine Plasma Membrane Transport Proteins
Female
Humans
Male
Myocardial Perfusion Imaging*
Parkinson Disease / diagnostic imaging*
Radiopharmaceuticals*

Substances

Dopamine Plasma Membrane Transport Proteins
Radiopharmaceuticals
3-Iodobenzylguanidine